Literature DB >> 17143962

Expression of semaphorin 6D in gastric carcinoma and its significance.

Xiang-Yang Zhao1, Lin Chen, Qian Xu, Yu-Hong Li.   

Abstract

AIM: To investigate the protein and mRNA expression of semaphorin 6D in gastric carcinoma and its significance.
METHODS: The protein and mRNA expression of semaphorin 6D was detected by semi-quantitative reverse transcription PCR and Western blotting respectively in 30 cases of gastric carcinoma and normal gastric mucosa.
RESULTS: The protein and mRNA expression of semaphorin 6D in gastric carcinoma was significantly higher than that in normal gastric mucosa (0.24 +/- 0.06 vs 0.19 +/- 0.07, 0.26 +/- 0.09 vs 0.20 +/- 0.10, P < 0.05).
CONCLUSION: Semaphorin 6D may play an important role in the occurrence and development of gastric carcinoma, and is related to tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143962      PMCID: PMC4087504          DOI: 10.3748/wjg.v12.i45.7388

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

Review 1.  Semaphorins and their receptors in vertebrates and invertebrates.

Authors:  J A Raper
Journal:  Curr Opin Neurobiol       Date:  2000-02       Impact factor: 6.627

2.  Identification, characterization, and functional study of the two novel human members of the semaphorin gene family.

Authors:  Xianghu Qu; Handong Wei; Yun Zhai; Haiping Que; Qian Chen; Fei Tang; Yan Wu; Guichun Xing; Yunping Zhu; Shaojun Liu; Ming Fan; Fuchu He
Journal:  J Biol Chem       Date:  2002-07-10       Impact factor: 5.157

3.  Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2.

Authors:  Toshihiko Toyofuku; Hong Zhang; Atsushi Kumanogoh; Noriko Takegahara; Fumikazu Suto; Junko Kamei; Kazuhiro Aoki; Masanori Yabuki; Masatsugu Hori; Hajime Fujisawa; Hitoshi Kikutani
Journal:  Genes Dev       Date:  2004-02-20       Impact factor: 11.361

4.  Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.

Authors:  John R Basile; Rogerio M Castilho; Vanessa P Williams; J Silvio Gutkind
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 5.  The sema domain.

Authors:  Ermanno Gherardi; Christopher A Love; Robert M Esnouf; E Yvonne Jones
Journal:  Curr Opin Struct Biol       Date:  2004-12       Impact factor: 6.809

Review 6.  The molecular biology of axon guidance.

Authors:  M Tessier-Lavigne; C S Goodman
Journal:  Science       Date:  1996-11-15       Impact factor: 47.728

Review 7.  Tumorigenesis and the angiogenic switch.

Authors:  Gabriele Bergers; Laura E Benjamin
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

8.  Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B.

Authors:  John R Basile; Ana Barac; Tianqing Zhu; Kun-Liang Guan; J Silvio Gutkind
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

Review 9.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

10.  Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.

Authors:  H Q Miao; S Soker; L Feiner; J L Alonso; J A Raper; M Klagsbrun
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

View more
  11 in total

Review 1.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis.

Authors:  Yanjie Lu; Qian Xu; Lei Chen; Yanzhen Zuo; Shaochen Liu; Yatao Hu; Xiaoru Li; Yuhong Li; Xiangyang Zhao
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

Review 3.  Semaphorins and their receptors in lung cancer.

Authors:  Vincent A Potiron; Joëlle Roche; Harry A Drabkin
Journal:  Cancer Lett       Date:  2008-07-14       Impact factor: 8.679

4.  The role of semaphorins and their receptors in gliomas.

Authors:  Janice Wai Sze Law; Alan Yiu Wah Lee
Journal:  J Signal Transduct       Date:  2012-09-23

5.  microRNAs' differential regulations mediate the progress of Human Papillomavirus (HPV)-induced Cervical Intraepithelial Neoplasia (CIN).

Authors:  Wenjuan Mo; Chao Tong; Yan Zhang; Hong Lu
Journal:  BMC Syst Biol       Date:  2015-02-07

6.  Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.

Authors:  Yimin Zhu; Hanlin Lu; Dandan Zhang; Meiyan Li; Xiaohui Sun; Ledong Wan; Dan Yu; Yiping Tian; Hongchuan Jin; Aifen Lin; Fei Gao; Maode Lai
Journal:  Clin Epigenetics       Date:  2018-03-02       Impact factor: 6.551

7.  CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway.

Authors:  Wei Li; Lin Dong; Fangfei Qu
Journal:  J Mol Histol       Date:  2020-05-29       Impact factor: 2.611

Review 8.  Functions of Plexins/Neuropilins and Their Ligands during Hippocampal Development and Neurodegeneration.

Authors:  Vanessa Gil; José Antonio Del Río
Journal:  Cells       Date:  2019-02-28       Impact factor: 6.600

9.  Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/β-Catenin/Cyclin D1 Pathway.

Authors:  Yu-Hsuan Hung; Shih-Han Hsu; Ya-Chin Hou; Pei-Yi Chu; Yung-Yeh Su; Yan-Shen Shan; Wen-Chun Hung; Li-Tzong Chen
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

Review 10.  Neuropilin-1 in transplantation tolerance.

Authors:  Mauricio Campos-Mora; Rodrigo A Morales; Tania Gajardo; Diego Catalán; Karina Pino-Lagos
Journal:  Front Immunol       Date:  2013-11-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.